Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Serina Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 33 | −4 |
| Shares | 4.85M | 200 | 4.79M | −63.0K (−1.3%) |
| Value | $5.28M | $0 | $4.09M | −$1.19M (−22.6%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 2,571 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Virtu Financial LLC | 33,314 | $36.0K |
| Jane Street Group, LLC | 28,116 | $31.0K |
| Millennium Management LLC | 13,115 | $14.0K |
| Chilton Capital Management LLC | 40 | $0 |
| CoreCap Advisors, LLC | 10 | – |
Not filed for Q1 2022 yet (1)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Reilly Financial Advisors, LLC | 200 | $0 |